CRISPR Therapeutics AG Insider Trading for December 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CRISPR Therapeutics AG.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in CRISPR Therapeutics AG for December 2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 30 2020 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Executive Off ... | Option Exercise | M | 1.81 | 13,800 | 24,978 | 128,983 | |
Dec 30 2020 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Executive Off ... | Buy | M | 1.81 | 13,800 | 24,978 | 182,989 | 169.2 K to 183 K (+8.16 %) |
Dec 22 2020 | CRSP | CRISPR Therapeutic ... | Ho Tony W | Executive VP, Head ... | Option Exercise | M | 16.90 | 23,551 | 398,012 | 236,449 | |
Dec 22 2020 | CRSP | CRISPR Therapeutic ... | Ho Tony W | Executive VP, Head ... | Sell | S | 150.61 | 2,951 | 444,450 | 33,964 | 36.9 K to 34 K (-7.99 %) |
Dec 22 2020 | CRSP | CRISPR Therapeutic ... | Ho Tony W | Executive VP, Head ... | Sell | S | 149.73 | 5,000 | 748,650 | 36,915 | 41.9 K to 36.9 K (-11.93 %) |
Dec 22 2020 | CRSP | CRISPR Therapeutic ... | Ho Tony W | Executive VP, Head ... | Sell | S | 148.38 | 8,400 | 1,246,392 | 41,915 | 50.3 K to 41.9 K (-16.69 %) |
Dec 22 2020 | CRSP | CRISPR Therapeutic ... | Ho Tony W | Executive VP, Head ... | Sell | S | 147.05 | 1,400 | 205,870 | 50,315 | 51.7 K to 50.3 K (-2.71 %) |
Dec 22 2020 | CRSP | CRISPR Therapeutic ... | Ho Tony W | Executive VP, Head ... | Sell | S | 152.41 | 500 | 76,205 | 51,715 | 52.2 K to 51.7 K (-0.96 %) |
Dec 22 2020 | CRSP | CRISPR Therapeutic ... | Ho Tony W | Executive VP, Head ... | Sell | S | 151.58 | 1,100 | 166,738 | 52,215 | 53.3 K to 52.2 K (-2.06 %) |
Dec 22 2020 | CRSP | CRISPR Therapeutic ... | Ho Tony W | Executive VP, Head ... | Sell | S | 150.16 | 1,600 | 240,256 | 53,315 | 54.9 K to 53.3 K (-2.91 %) |
Dec 22 2020 | CRSP | CRISPR Therapeutic ... | Ho Tony W | Executive VP, Head ... | Sell | S | 149.18 | 900 | 134,262 | 54,915 | 55.8 K to 54.9 K (-1.61 %) |
Dec 22 2020 | CRSP | CRISPR Therapeutic ... | Ho Tony W | Executive VP, Head ... | Sell | S | 148.11 | 1,700 | 251,787 | 55,815 | 57.5 K to 55.8 K (-2.96 %) |
Dec 22 2020 | CRSP | CRISPR Therapeutic ... | Ho Tony W | Executive VP, Head ... | Buy | M | 16.90 | 23,551 | 398,012 | 57,515 | 34 K to 57.5 K (+69.34 %) |
Dec 18 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 151.05 | 931 | 140,625 | 339,834 | 340.8 K to 339.8 K (-0.27 %) |
Dec 18 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 151.05 | 969 | 146,365 | 0 | 969 to 0 (-100.00 %) |
Dec 18 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 150.14 | 958 | 143,837 | 340,765 | 341.7 K to 340.8 K (-0.28 %) |
Dec 18 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 150.14 | 995 | 149,392 | 969 | 2 K to 969 (-50.66 %) |
Dec 18 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 149.12 | 2,009 | 299,586 | 341,723 | 343.7 K to 341.7 K (-0.58 %) |
Dec 18 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 149.12 | 2,091 | 311,815 | 1,964 | 4.1 K to 2 K (-51.57 %) |
Dec 18 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 148.28 | 2,576 | 381,972 | 343,732 | 346.3 K to 343.7 K (-0.74 %) |
Dec 18 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 148.28 | 2,679 | 397,245 | 4,055 | 6.7 K to 4.1 K (-39.78 %) |
Dec 18 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 147.00 | 878 | 129,068 | 346,308 | 347.2 K to 346.3 K (-0.25 %) |
Dec 18 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 147.00 | 914 | 134,360 | 6,734 | 7.6 K to 6.7 K (-11.95 %) |
Dec 14 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 144.85 | 15,900 | 2,303,155 | 314,186 | 330.1 K to 314.2 K (-4.82 %) |
Dec 14 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 143.26 | 2,223 | 318,462 | 330,086 | 332.3 K to 330.1 K (-0.67 %) |
Dec 14 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 142.42 | 5,958 | 848,562 | 332,309 | 338.3 K to 332.3 K (-1.76 %) |
Dec 14 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 141.54 | 6,648 | 940,923 | 338,267 | 344.9 K to 338.3 K (-1.93 %) |
Dec 14 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 140.62 | 2,271 | 319,345 | 344,915 | 347.2 K to 344.9 K (-0.65 %) |
Dec 11 2020 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Executive Off ... | Option Exercise | M | 1.81 | 20,000 | 36,200 | 142,783 | |
Dec 11 2020 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Executive Off ... | Sell | S | 144.97 | 600 | 86,982 | 169,189 | 169.8 K to 169.2 K (-0.35 %) |
Dec 11 2020 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Executive Off ... | Sell | S | 143.71 | 2,100 | 301,791 | 169,789 | 171.9 K to 169.8 K (-1.22 %) |
Dec 11 2020 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Executive Off ... | Sell | S | 142.75 | 6,766 | 965,847 | 171,889 | 178.7 K to 171.9 K (-3.79 %) |
Dec 11 2020 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Executive Off ... | Sell | S | 141.98 | 5,034 | 714,727 | 178,655 | 183.7 K to 178.7 K (-2.74 %) |
Dec 11 2020 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Executive Off ... | Sell | S | 141.17 | 5,500 | 776,435 | 183,689 | 189.2 K to 183.7 K (-2.91 %) |
Dec 11 2020 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Executive Off ... | Buy | M | 1.81 | 20,000 | 36,200 | 189,189 | 169.2 K to 189.2 K (+11.82 %) |
Dec 10 2020 | CRSP | CRISPR Therapeutic ... | KASINGER JAMES R. | General Counsel and ... | Option Exercise | M | 13.62 | 22,026 | 299,994 | 100,974 | |
Dec 10 2020 | CRSP | CRISPR Therapeutic ... | KASINGER JAMES R. | General Counsel and ... | Buy | M | 13.62 | 22,026 | 299,994 | 22,415 | 389 to 22.4 K (+5,662.21 %) |
Dec 03 2020 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Executive Off ... | Payment of Exercise | F | 129.58 | 779 | 100,943 | 169,189 | 170 K to 169.2 K (-0.46 %) |
Dec 02 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Option Exercise | M | 14.43 | 50,000 | 721,500 | 140,315 | |
Dec 02 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Option Exercise | M | 14.00 | 50,000 | 700,000 | 61,893 | |
Dec 02 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Sell | S | 125.00 | 50,000 | 6,250,000 | 648,007 | 698 K to 648 K (-7.16 %) |
Dec 02 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Buy | M | 14.43 | 50,000 | 721,500 | 698,007 | 648 K to 698 K (+7.72 %) |
Dec 02 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Sell | S | 125.00 | 50,000 | 6,250,000 | 648,007 | 698 K to 648 K (-7.16 %) |
Dec 02 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Buy | M | 14.00 | 50,000 | 700,000 | 698,007 | 648 K to 698 K (+7.72 %) |